Modernizing CMV Preventive Approaches
Listen to Hannah Imlay, MD, MS, explore concepts in CMV prevention in solid organ transplantation, including comparison of prevention strategies, international guideline recommendations, monitoring strategies, and future prevention approaches.
Decera Clinical Education Infectious Disease Podcast · Hannah Imlay MD MS
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Hannah Imlay, MD, MS, discusses cytomegalovirus (CMV) prevention strategies in solid organ transplantation (SOT) recipients including:
- Strategies for preventing CMV in SOT
- International guideline recommendations for CMV prevention strategies by organ type
- Antivirals used for CMV prevention
- Comparison of preemptive therapy vs prophylaxis for CMV prevention in liver transplant recipients
- Comparison of letermovir vs valganciclovir for CMV prophylaxis in kidney transplant recipients
- Use of CMV cell–mediated immunity monitoring for primary prophylaxis
- Monitoring CMV viral loads, including limitations to quantitative nucleic acid testing
- Future prevention approaches
Faculty:
Hannah Imlay, MD, MS
Assistant Professor of Medicine
Department of Internal Medicine, Division of Infectious Diseases
University of Utah
Salt Lake City, Utah
Content based on a CME program supported by an educational grant from Merck & Co., Inc., Rahway, NJ, USA.
Follow along with a downloadable slideset at:
https://bit.ly/476v2wI
Link to full program:
https://bit.ly/47lNK2K
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.